Oncologic, Endocrine & Metabolic Overview: Recent advances in implants for bone growth promotion

References to Primarv Literaturess

• KENLEY RA, YIM K, ABRAMS J, RON E, TUREK T, MARDEN• Lj, HOLLINGER JO: Biotechnology and bone graft substi-tutes. Pharm. Res. (1993) 10: 1393–1401. Excellent review article for overall bone growth promoter applica-tions.
   Google Scholar
• ANDERSON HC: Recent advances in methods for induc-big bone formation. Curr. Opin. 7ber. Patents (1994) 4: 17–29. Excellent review article for overall bone growth promoter applica-tions.
   Google Scholar
• DANIELS AU, CHANG MKO, ANDIANO KP, IIELLER J: Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone. J. Appl. Biomat. (1990) 1: 57–78. MAJOLA A,VALNIONPAA S, VIHTONEN K, MERO M, VASENIUS J, TORMALA P, ROKKANEN P: Absorption, biocompatibility, and fixation properties of polylactic acid in bone tissue: an experimental study in rats. Clin. Ortho. (1991) 268: 260–269.
   Google Scholar
• URIST MR: Bone formation by auto induction. Science(1965) 150: 893–899. A classic article regarding the use of bone materials in bone growth promotion.
   Google Scholar
• KUBLER N, URIST MR: Allogenic bone & cartilage mor-phogenesis. J. CranioMax. Fac. Sum. (1991) 19: 283–288.
   PubMedGoogle Scholar
• JOHNSON EE, URIST MR, FINERMAN GAM: Resistant nonunions & partial or complete segmental defects of long bones. Clin. Ortho. Rel. Res. (1992) 277: 229–237.
   PubMedGoogle Scholar
• GERHART TN, KIRKER-HEAD CA, VET MB, KRIZ MJ, HOL-TROP ME, HENNIG GE, HIPP J, SCHELLING SH, WANG E: Healing segmental femoral defects in sheep using re-combinant human bone morphogenetk protein. Clin. Ortho. Rel. Res. (1993) 293: 317–326.
   PubMedGoogle Scholar
• WANG EA, ROSEN V, D'ALESANDRO JS, BAUDUY M: Re-combinant human bone morphogenic protein induced bone formation. Proc. Natl. Acad. Sci. USA (1990) 87: 2220–2224.
   PubMed Web of Science ®Google Scholar
• YASKO AW, LANE JM, FELLINGER EJ, ROSEN V, WOZNEYJM, WANG EA: The healing of segmental bone defects, Induced by recombinant human bone morphogenic protein (rhBMP-2) - a radiographic, histological, and biomechanical study in rats.J. BoneJoint Sum. Am. (1992) 74: 659–670.
   PubMed Web of Science ®Google Scholar
• TORIUMI DM, KOLTER HS, LUXENBERG DP, HOLTROP ME,WANG EA: Mandibular reconstruction with a recombi-nant bone-inducing factor. Arch. Otolaryngol Neck Sum. (1991) 117: 1101–1112.
   PubMedGoogle Scholar
• KIBBLEWHITE DJ, BRUCE AG, STRONG DM, OTT SM, PURCHIO AF, LARRABEE WE: Transforming growth fac-tor-beta accelerates osteoinduction in a craniofadal °Way model. Growth Factors (1993) 9: 185–193.
   PubMed Web of Science ®Google Scholar
• KATOH T, SATO K, KAWAMURA M, IWATA H. MIURA T:Osteogenesis in sintered bone combined with bovine bone morphogenetk protein. Clin. Ortho. Rel. Res. (1993) 287: 266–275.
   Google Scholar
• MIYAMOTO S, TAKAOKA K, OKADA T, YOSHIKAWA H,HASHIMOTO J, SUZUKI S, ONO K: Evaluation of polylac- tic add homopolymers as carriers for bone morpho-genetic protein. Clin. Ortho. Rel. Res. (1992) 278: 274–285.
   PubMedGoogle Scholar
• MIYAMOTO S, TAKAOKA K, OKADA T, YOSHIKAWA H,HASHIMOTO J, SUZUKI S, ONO K: Polylactic acid poly-ethylene glycol block copolymer. Clin. Orth. Rel. Res. (1993) 294: 333–343.
   Google Scholar
• JOHNSON EE, URIST MR, FINERMAN GA: Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and hu-man bone morphogenic protein (hBMP). Clin. Orthop. (1990) 250: 234–240.
   Google Scholar
• McCORMACK AP, ANDERSON PA, TENCER AF: Effect ofcontrolled local release of sodium fluoride on bone formation: filling a defect in the proximal femoral cortex. J, Ortho. Res. (1993) 11: 548–555.
   PubMedGoogle Scholar
• ANDERSON PA, COPENHAVER JC, TENCER AF, CLARK JM:Response of cortical bone to local controlled release of sodium fluoride: the effect of implant insertion site. J. Ortho. Res. (1991) 9: 890–901.
   PubMedGoogle Scholar
• GOMBOTZ WR, PANKEY SC, BOUCHARD LS, RANCHALISJ, PUOLAKKAINEN P: Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration. J. Biomater. Sci. Polym. Ed. (1993) 5: 49–63.
   PubMed Web of Science ®Google Scholar
• TURK AE, ISHIDA K, JENSEN JA, WOLLMAN JS, MILLER TA: Enhanced healing of large cranial defects by an osteoin-ductive protein in rabbits. Plast. Reconstruct. Sum. (1993) 92(4): 593–600.
   Google Scholar
• KLEINSCHMIDT JC, MARDEN LJ, KENT D, QUIGLEY N, HOLLINGER JO: A multiphase system bone implant for regenerating the calvaria. Plast. Reconstruct. Stag. (1993) 92(4): 593–600.
   PubMedGoogle Scholar
• PINHOLT EM, SOLHEIM E, BANG G, SUDMANN E: Boneinduction by composite of bioerodible polyorthoester and demineralized bone matrix in rats. Ada Orthop. Scand. (1991) 62(5): 476–480.
   PubMed Web of Science ®Google Scholar
• SOLHEIM E, PINHOLT EM, BANG G, SUDMANN E: Regen-eration of calvarial defects by a composite of bio-erodible polyorthoester and demineralized bone in rats. J. Neurosum. (1992) 76(2): 275–279.
   PubMedGoogle Scholar
• SOLHEIM E, PINHOLT EM, BANG G, SUDMANN E: Effect of local hemostatics on bone induction in rats: a com-parative study of bone wax, fibrin-collagen paste, and bioerodible polyorthoester with and without gen-tarnidn. J. Biomed. Mater. Res. (1992) 26(6): 791–800.
   PubMed Web of Science ®Google Scholar
• SOLHEIM E, PINHOLT EM, ANDERSEN R, BANG G, SUD-MANN E: The effect of a composite of polyorthoester and &mineralized bone on the healing of large seg-mental defects of the radius of rats. J. Bone Joint Sum. Am. (1992) 74(10): 1456–1463.
   PubMedGoogle Scholar
• PINHOLT EM, SOLHEIM E, BANG G, SUDMANN E: BoneInduction by composites of bioresorbable carriers and demineralized bone in rats. J. Oral Maxillofac. Sum. (1992) 50: 1300–1304.
   PubMedGoogle Scholar
• SOLHEIM E, PINHOLT EM, BANG G, SUDMANN E: Inhibi-tion of heterotopk osteogenesis in rats by a new bio-erodible system for local delivery of indomethacin. BoneJoint Surg. Am. (1992) 74(5): 705–712.
   PubMed Web of Science ®Google Scholar
• ONO I, OHLTRA T, MURATA M, YAMAGUCHI H, OHNUMAY, KUBOKI Y: A study on bone induction in hydroxya-patite combined with bone morphogenic protein. Plast. Reconstr. Sum. (1992) 90(5): 870–879.
   PubMedGoogle Scholar
• SATO T, ICAWAMURA M, SATO K, IWATA H, MIURA T: Bonemorphogenesis of rabbit bone morphogenic protein-bound hydroxyapatite-fibrin complex. ain. Orthop. (1991) 263: 254–262.
   Google Scholar
• NISHINO T: Experimental study on hydroxyapatite soadIn sodium fluoride - with special reference to bone formation. Nippon Seikeigeka Gakkai Zasshi (1991) 65(12): 1199–1210.
   PubMedGoogle Scholar
• HORISAKE Y, OKAMOTO Y, MATSUMOTO N, YOSHIMURAY, KAWANDA J, YAMASHITA K, TAKAGI T: Subperiosteal implantation of bone morphogenic protein absorbed to hydroxyapatite. Gin. Orthop. (1991) 268: 303–312.
   Google Scholar
• UMEMURA M, KAWAI T, MIEKI A, KATAOKA H, KURITA S, KOIE M, KISHI M, OHNO Y, HASEGAWA J: Bone induced activity of hydroxyapatite-bone morphogenic protein complex. Nippon Shishubyo Gakkai Kaishi (1989) 31(93): 860–869.
   Google Scholar
• MILLER SC, MARKS SC: Alveolar bone augmentation following the local administration of prostaglandin El by controlled release pellets. Bone (1993) 14: 587–593.
   PubMedGoogle Scholar
• YAMAMURA K, IWATA H, YOTSUYANAGI T: Synthesis ofantibiotic-loaded hydroxyapatite beads and in vitro drug release testing. J. Biomed. Mater. Res. (1992) 26(8): 1053–1064.
   PubMed Web of Science ®Google Scholar
• YU D, WONG J, MATSUDA Y, FOX JL, HIGUCHI WI, OTSUKA M: Self-setting hydroxyapatite cement: a novel skeletal drug-delivery system. J. Pharm. Sci. (1992) 81(6): 529–531.
   PubMed Web of Science ®Google Scholar
• YU D, TSAI CL, WONG J, FOX JL: Hydroxyapatite cementbased drug delivery systems: drug release in vitro. J. Formos Med. Assoc. (1991) 90(10): 953–957.
   Google Scholar
• TAKE ZAWA Y: Studies on physico-chemical propertiesof self-setting apatite cement. Gifu Shika Gakkai Zasshi (1989) 16(2), 500–519. References to Patent Literature
   Google Scholar
• LUCOCR AKTIEBOLAG, W09313815 (1992).
   Google Scholar
• PFIZER HOSPITAL PRODUCTS GROUP, US5263985 (1993).
   Google Scholar
• GENETICS INSTITUTE, W09300050 (1991).
   Google Scholar
• GENETICS INSTITUTE, U55171579 (1992).
   Google Scholar
• STRYICER CORPORATION, US4968590 (1990).
   Google Scholar
• CREATIVE BIOMOLECULES, US5108753 (1992).
   Google Scholar
• BRISTOL-MYERS SQUIBB CO, EP-567391A (1993).
   Google Scholar
• MERCK & CO, W09315767 (1992).
   Google Scholar
• COLLAGEN CORP, US5108436 (1993).
   Google Scholar
• COLLAGEN CORP, U55207710 (1993).
   Google Scholar
• COLLAGEN CORP, US5258029 (1993).
   Google Scholar
• ROBERT FRANCIS SHAW, US5270300 (1993).
   Google Scholar
• CELTRIX PHARMACEUTICALS INC, EP-512844A (1993).
   Google Scholar
• SOUTHWEST RESEARCH INSTITUTE, US5294446 (1994).
   Google Scholar
• GENENTECH INC, W09415653 (1994). Leah E Appel, INTERx Research Division, Merck & Co Inc, 2201 W 21st St, Lawrence, KS 66047, USA
   Google Scholar